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Abstract The present study aimed to compare the cellular pattern and structural changes in the airways of patients
with primary Sj˛gren’s syndrome (pSS) with healthy controls. Bronchial biopsy specimens were obtained from seven
subjects with pSS and seven healthy controls. All the patients with pSS had increased bronchial responsiveness to
methacholine.Inthebiopsiesin£ammatorycells, cytokine-producingcells, tenascin andlamininwerevisualizedbyimmu-
nostaining.PatientswithpSShadahighernumberofneutrophils andmastcells thanhealthycontrols, whilethenumberof
eosinophilswas similarinthetwogroups.Thenumberof IL-8-positive cellswashigherinpSSbutthenumbersof IL-4-and
IL-5-positive cells were not signi¢cantly di¡erent between pSS and healthy controls.The numbers of T cells in patients
with pSS were higher than in healthy controls, while the numbers of CD25-positive cells were similar to the healthy
controls.The degree of epithelial integrity in patientswith pSSwas signi¢cantly lower than in the control group and the
tenascin and laminin layers were signi¢cantly thicker in the pSS group.Therewas a correlation between the number of
mastcells andthethicknessofthetenascin andlamininlayersinpSS.Inconclusion, we foundthatthe cellularpatterninthe
bronchial mucosa of patients with pSS displayed large numbers of neutrophils, mast cells and T-lymphocytes. These
changes in in£ammatory cell numbers seemed to relate to the observed increased epithelial damage and structural
changes of the subepithelium.The structural ¢ndings, but not the pattern of in£ammatory cells, are sharedwith atopic
asthma andmayrelate to the increased bronchialhyper-responsiveness seen in both diseases.c 2001Harcourt Publishers Ltd
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Primary Sj˛gren’s syndrome (pSS) is a chronic auto-
immune in£ammatorydisease, characterizedby lympho-
cytic and plasma cell in¢ltration, mainly in exocrine
glands. Lung involvement is common in pSS (1) and the
invasion of the lower respiratory tract by lymphocytic
and plasma cell in¢ltrates in the mucous glands of the
small airways gives rise to focal atelectasis and bronch-
iectasis, as well as lymphocytic pneumonitis and small
airway disease (1). Patients with pSS, especially those
who, in addition to glandular symptoms, su¡er from
extraglandular symptoms, frequently have bronchialReceived19 April 2001, accepted in revised form 21June 2001and
published online13 September 2001.Correspondence should be
addressed to: Kawa Amin,Department of Genetics and Pathology,
Rudbeck Laboratory C11,University of Uppsala, SE-75185 Uppsala,
Sweden.Fax: +46-18-513810; E-mail: kawa.amin@genpat.uu.sehyper-responsiveness (BHR) (2^4) but are less reactive
to indirect bronchial provocation agents such as adeno-
sine monophosphate and cold air than patients with
atopic asthma (4). In commonwith patientswith asthma,
patients with pSS often have increased levels of nitric
oxide in exhaled air (5).
Thereason for the occurrence of BHR inpatientswith
pSS is not known.Gudbj˛rnsson et al. (3) speculated that
it could be due to the presence of in£ammatory cells in
the airways, or that it could be related to xerotracheitis
sicca and secondary to drymucousmembranes.
We hypothesized that the in£ammation in the lungs,
underlying BHR, of patients with pSSmight involve simi-
lar mechanisms as that of patients with asthma.The aim
of this study was therefore to compare the cellular
patterns and structural changes in the airways of bron-
chial hyper-reactive patients with pSS with those found
in healthy controls.
Table 1. Patientcharacteristics (mean andrange)
Healthycontrols
(n=7)
Sj˛gren’s syndrome
(n=7)
Age (yrs) 30 (22^44) 51 (43^61){
Sex (M/F) 2/5 0/7
FEV1 (% pred) 98 (77^120) 85 (71^93)*
FVC (% pred) 95 (78^109) 86 (66^99)
PC20 (mgml
71) ^ 14.7 (0.7^32)
FEV1: forced expiratory volume in1);FVC: forcedvital capacity,PC20: provocation concentrationthat reduces FEV1by 20%.
*P50?05 and {0?01comparedwith controls.
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Subjects
Bronchialbiopsieswere collected from14 adults (Table1),
seven with pSS and seven healthy controls (Table 1).The
participants formedpart of a larger group included in an
ongoing study of the pathophysiology of BHR (4^6).
Thepatientswith primarypSSwerebeing followedup
as outpatients at the Department of Rheumatology,
Uppsala University Hospital. The diagnosis of primary
Sj˛gren’s syndromewasbasedon theCopenhagen criter-
ia (7). None of the patients were being treated with in-
haled glucocorticosteroids, but two had inhaled
b-agonists as needed andonehad inhaled sodiumcromo-
glycate. All the patients displayed an increased respon-
siveness to inhaled methacholine, de¢ned by a
provocative dose of methacholine causing a 20% fall in
forced expiratory volume in 1sec (FEV1) PC20 532mg
(see below). All the patients were non-smokers and had
been free from respiratory infections for at least 6
weeks prior to the study.
Controls were healthy subjects responding to a
request for volunteers; none had asthmatic symptoms or
was receiving anti-asthmatic treatment. All had a nega-
tive skinprick test. Allwerenon-atopic andnon-smokers.
The study was conducted in accordance with the De-
claration of Helsinki and was approved by the ethics
committee at the Faculty of Medicine at the University
of Uppsala.
Laboratory procedures
Spirometry
Forced vital capacity (FVC) and FEV1 were measured
using a Masterlab Trans spirometer (Eric Jaeger AG,
Wˇrzberg,Germany).
Methacholine tests
An automatic, Spira Elektro 2 inhalation dosimeter (Re-
spiratory Care Centre, Hameenlinna, Finland) was used(8).The provocationwas continued by doubling the con-
centrations ofmethacholineuntil the FEV1haddecreased
by 20% or the highest concentration (32mgml71) was
reached. Baseline values were measured after an inhala-
tion of saline. The methacholine provocation was per-
formed on average 5?8 months before the
bronchoscopy.The mean PC20 values from these provo-
cations are presented inTable 1. All the control subjects
were negative to the methacholine provocation (PC20
values432mgml71).
Bronchoscopy
Patients were given 10mg of diazepam (Stesolid1, Du-
mex, Copenhagen, Denmark) orally and 0?5mg of atro-
pine (Atropine, NM Pharma, Stockholm, Sweden)
subcutaneously 30min before the investigation. The
upper airways were anaesthetizedwith lidocaine hydro-
chloride (Xylocaine, Astra, S˛dertÌlje, Sweden).Using a
£exible ¢bre bronchoscope (Olympus P 20D) with a FB
15C 2?0mm forceps (Olympus, Tokyo, Japan), two biop-
sies were taken in the right lung in the superior lobar
bronchus immediately after the division from the main
bronchus. The specimens were examined immediately
under a light microscope to ensure the presence of a
completemucosa and processed as described below.
Immunohistochemistry
Frozen sections
One of the bronchial biopsy specimens taken from the
upper lobe was frozen immediately and rapidly in
propane cooled downwith liquid nitrogen.
Themethodused in the immunohistochemical analysis of
the biopsies has been described in detail in a previous
paper (6).
Monoclonal antibodies
The eosinophils, neutrophils and mast cells were identi-
¢ed with monoclonal antibodies. To ensure a reliable
906 RESPIRATORYMEDICINEcount of neutrophils, two di¡erent antibodies, human
neutrophil lipocalin (HNL) (Pharmacia & Upjohn Biosen-
sors, Uppsala, Sweden) and myeloperoxidase (MPO)
(Dako,Glostrup,Denmark), wereused for identi¢cation.
The monoclonal antibodies EG1 (eosinophil cationic
protein; ECP) and EG2 (eosinophil cationic protein/
eosinophil protein-X; ECP/EPX) (Pharmacia & Upjohn
Diagnostics AB) were used for the identi¢cation of eosi-
nophils. The anti-tryptase antibody 1, AA1 (Dako), was
used for the identi¢cation of mast cells. For the localiza-
tion of interleukins 4 and 5 (IL-4 and IL-5), mouse anti-
human IL-4 and rat anti-human IL-5 were used. Both
antibodies came from PharMingen (San Diego, CA,
U.S.A.). Monoclonal mouse anti-IL-8 (Pharmacia & Up-
john, Diagnostics AB) was used on frozen sections at a
concentration of 0?002mgml71. A panel of monoclonal
antibodies including anti-CD3, CD4, CD8 and CD25
(IL-2 receptor) was used to identify various types of
T-lymphocyte (Dako).
Tenascin and laminin in cryosections
Frozen sections were thawed and ¢xed in acetone at
7208C for10min prior to the addition of the monoclo-
nal antibodies to tenascin and laminin (Dako).
Plastic-embedded tissue formorphology
Formorphological studies, lightmicroscopy was carried
out on glycolmethacrylate (GMA), (Agar Aids, Stansted,
U.K.) embedded tissue as describedpreviouslyby Britten
(9). Sectionswith a thickness of 2mmwere cutwith glass
knives on an LKB Historange Microtome (LKB Instru-
ments, Bromma, Sweden).
Microscopic evaluation of sections
All the specimens were coded and examined by the mi-
croscopist without any knowledge of the diagnosis.The
number of labelled cells in the tissuewas countedmanu-
ally at amagni¢cation of640.One¢eldof approximately
0?8mm2was selected a random.This ¢elddidnot include
glands and muscle cells. One ¢eld was analysed in each
section.
The epithelial integrityof thebronchialwall of the sub-
jects from the di¡erent groups was assessed by light mi-
croscopy in plastic sections stained with Mayer’s
haematoxylin. The total length of the basement mem-
brane and the length of intact epithelium in the section
through each biopsy were determined. Epithelial integ-
rity was de¢ned as the length of basal membrane with
intact epithelium divided by the total length of the
membrane.
Themeasurement of the thickness of the tenascin and
laminin layers (in mm) was performed in 4-mm thickimmunolabelled frozen sections using a 640 objective
and a computerized image analysis system as described
above.
Statistics
All the statistics were calculated using non-parametric
tests. Comparisons between the two groups were per-
formedwith theMann^WhitneyU-test.For correlations
within a group, Spearman’s rank correlation test was
used. A P-value of 50?05 was regarded as statistically
signi¢cant.
RESULTS
The patients with pSS were signi¢cantly older than the
healthy controls. There was also signi¢cantly di¡erence
of FEV1 in patients with pSS compared with healthy
controls (Table1).
In£ammatory cells and cytokines
The number of neutrophils (HNL- and MPO-positive
cells) was higher in patients with pSS than in healthy
controls, but there was no signi¢cant di¡erence in the
numbers of eosinophils (EG1- and EG2-positive cells).
The numbers of mast cells were increased in patients
with pSS compared to the control group (Table 2).
The total number of T-lymphocytes and the numbers
of CD3-, CD4-, CD8-positive cells were increased in
the pSS group (Table 2), whereas the numbers of CD25-
positive cells were similar in pSS and healthy controls
(Table 2).
The numbers of cells expressing cytokines in the
two groups are shown inTable 2. IL-4-positive cells and
IL-5-positive cells were similar in pSS and healthy
controls, whereas patients with pSS had signi¢cantly
higher numbers of IL-8 -expressing cells (Table 2).
IL-8 was mainly found in bronchial epithelial cells and
neutrophils.
Correlation between in£ammatory cells
In the patients with pSS the numbers of MPO-positive
cells were correlated signi¢cantly with the numbers of
IL-8- (r=0?83) and CD4-positive cells (r=0?75)
(P50?05). A signi¢cant positive correlation was also
found between HNL- and IL-8 -positive cells in the pSS
group (r=0.88, P50?01).
Epithelial damage and structural changes
Patientswith pSS had lower epithelial integrity than con-
trols (Fig.1). In the damaged area, the cylindrical ciliated
epithelial cells were absent, while the layer of cuboidal
Table 2. Number of granulocytes,T-lymphocytes and cells expressing cytokine in bronchial biopsies (median and inter-quantity
range)
Healthycontrols
(n=7)
Sj˛gren’s syndrome
(n=7)
EG1 0 (0^1) 33 (0^49)
EG2 0 (0^1) 22 (6^56)
HNL 24 (12^25) 133 (122^200){
MPO 28 (26^30) 267 (155^333) {
AA1 6 (3^7) 56 (50^61) {
CD3 14 (11^15) 280 (240^360) {
CD4 8 (6.5^10) 190 (175^280) {
CD8 5 (5^6.5) 80 (62^86) {
CD25 0 (0^0) 0 (0^6)
IL-4 0 (0^0.5) 0 (0^5)
IL-5 0 (0^1) 0 (0^6)
IL-8 0 (0^5) 48 (45^56) {
EG: eosinophil granulocyte;HNL: humanneutrophil lipocalin;MPO: myeloperoxidase; AA1: anti-tryptase antibody1;CD: clus-
ters of di¡erentiation; IL: interleukin.
Results are given as positive cellsmm72.
{P5 0?001comparedwith controls.
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frequently found in the areas of epithelial damage
(Fig. 2).
The tenascin and laminin layers were thicker in
patients with pSS as compared to the healthy controls
(Fig. 3).
Correlations between in£ammatory cell
numbers and epithelial integrity or
structural changes
In pSS epithelial integrity was negatively correlated to
the numbers of eosinophils, CD3- and CD4-positive
T-lymphocytes, neutrophils and IL8-positive cellsFig. 1. A comparison of the epithelial integrity of the airway
wallinhealthycontrols (HC), andpatientswithprimarySj˛gren’s
syndrome (pSS).(Table 3). Positive correlations were found between the
numbers of mast cells and the thickness of either the
tenascin or the laminin layer (Table 3).
DISCUSSION
This study has shownmajor changes in the histopatholo-
gic characteristics of the lungs of patients with pSS and
increased responsiveness tometacholine.These patients
were characterized by high numbers of neutrophils,
mast cells and T-lymphocytes in their bronchial mucosa,
concomitant with a high number of IL-8-positive cells. In
contrast, the numbers of eosinophils seemed normal, as
did the numbers of cells staining positive for IL-4 and
IL-5. Our study also indicated that patients with pSS inFig 2. Resin (plastic) sections of a bronchial biopsywith HNL.
Neutrophils accumulation in areas of reduced epithelial integrity
is shown in a specimen from a patient with pSS.Mayer’s haema-
toxylin.Originalmagni¢cation6320.
Fig. 3. Structural changesinthe airways ofthe di¡erentgroups asindicatedby thethickness ofthe tenascin (a) andlaminin (b) layers
inthe subepitheliumof healthycontrols (HC), andpatientswith primary Sj˛gren’s syndrome (pSS).
908 RESPIRATORYMEDICINEcomparisonwith healthy controls have increased epithe-
lial damage and thickness of the tenascin and laminin
layers in the airways.
In a previous study we investigated the in£ammatory
and structural changes in the bronchial mucosa of an-
other group of patientswith increasedbronchial respon-
siveness to metacholine, i.e. bronchial asthma (6). A
rationale for comparing such patients with pSSwas that
previous studies have shown thatpatientswith pSS share
some characteristics with asthmatics, such as a high pre-
valence of airway symptoms and bronchial hyper-
responsiveness (2, 3). In the same group of patients as in
this study, it was found that both patients with pSS
and atopic asthma are associated with increased levels
of exhaled NO (10), while patients with pSS were
less likely to react to indirect bronchial provocation
stimuli than the atopic asthma group (4). The results of
this bronchoscopy study con¢rmed that there areTable 3. Correlation (r-values) between in£ammatorycellnumb
Cells Epithelial
integrity
EG1-positive 70?76*
EG2-positive 70?83*
MPO-positive 70?76*
HNL-positive 70?83*
AA1-positive 70?56
IL-47positive 70?35
IL-5-positive 70?34
IL-8-positive 70?88{
CD3-positive 70?70*
CD4-positive 70?86{
CD8-positive 70?52
CD25-positive 70?20
EG: eosinophil granulocyte;MPO: myloperoxidase;HNL: hum
ters of di¡erentiation; IL: interleukin.
*P50?05, {P50?01, {P50?001.distinct similaritiesbetweenpatientswithpSS and atopic
asthma regarding structural changes, but there are also
clear di¡erences in involvement of in£ammatory cells as
will be discussed below. It should, however, be empha-
sized again that the patients of this study were selected
because of their hyper-responsiveness to metacholine.
This be kept in mind when comparing of our data with
those of others studying in£ammatory and structural
changes in pSS.
The large numbers of neutrophils found in bronchial
biopsies inpatientswithpSS are in accordancewith those
studies reporting an increased number of neutrophils in
bronchial alveolar lavage (BAL) (11).The pSSbiopsies con-
tainedonly a feweosinophils,which also is in linewith the
results of Papirin etal. who used the haematoxylin^eosin
method and found no signi¢cant di¡erence in eosinophil
numbers between patients with pSS and controls (12).
Other authors, however, have found large numbers ofers and structural changes inpatientswith Sj˛gren’s syndrome
Tenascin
layer
Laminin
layer
0?54 70?34
0?49 0?02
0?02 70?36
0?59 0?43
0?80{ 0?56*
0?46 0?31
70.46 0?32
0?54 0?04
0?59 0?21
0?50 0?18
0?56 70?18
0?46 0?61
an neutrophil lipocalin; AA1: anti-tryptase antibody1; CD: clus-
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mast cells were increased in patients with pSS.
The role of airway mast cells in Sj˛gren’s syndrome is
notknown, but Skopoulietal. (14) showed thatmast cells
in the salivary glands of patients with primary pSS are
strongly associated with ¢brosis. This may indicate that
the increased number of mast cells in the bronchial mu-
cosa in pSS plays an important role in the airway pathol-
ogy of this disease; a notion that was further suggested
by the close association betweenmast cell numbers and
the thickness of the laminin and tenascin layers. We
found a similar close association in atopic asthma (6),
which further emphasizes a likely role of mast cells in
these processes.
A common feature of all the organs a¡ectedbypSS is a
dense lymphocyte in¢ltrate (15). It is thought that this in-
¢ltrate may cause functional changes in the a¡ected
organs and may be responsible for the diverse clinical
features of this syndrome. In the present investigation,
large numbers of lymphocytes (CD3-,CD4-,CD8-posi-
tive cells)were foundinpatientswithpSS comparedwith
healthy controls. Gudbj˛rnsson et al. (16, 17) have pre-
viously demonstrated increased levels of lymphocytes in
BAL £uid in pSS. Coll et al. (18) have shown high IL-2R
(CD25) expression in epithelial cells in the salivaryglands
of patients with pSS. In the present study we did not,
however, ¢nd any expression of CD25 in the epithelial
cells or other cells in bronchial biopsies from these
patients.
Our investigation showeda largenumberof IL-8-positive
cells in pSS. In addition to lymphocytes, IL-8 was predo-
minantly localizedinbronchial epithelial cells andneutro-
phils, whereas in patientswith atopic asthma eosinophils
seemed to the major containing cell (6).We did not ¢nd
many IL-4- and IL-5-positive cells in patients with pSS.
This result is in agreementwith Konttinen (19), indicating
that in£ammation in pSS is not driven byTh2-cells.
Damage to the bronchial epithelium has often been
reported in bronchial biopsy specimens of patients with
asthma (6, 20). Previously we showed that such damage
was a hallmark of atopic asthma, since it was not ob-
served in non-atopic asthma. In atopic asthma the
epithelial damage was correlated to the presence of eo-
sinophils in the mucosa (6). In this study on pSS we also
found a reduced epithelial integrity, although not to the
same extent as in atopic asthma.To our knowledge, in-
creased damage of bronchial epitheliumhas notbeende-
scribed before in patients with pSS. Suzuki et al. (21),
however, reported increased epithelial damage in the
eye of pSS.
The possible mechanism of damage of the bronchial
epithelium in pSS seems to bemuchmore complex than
in atopic asthma and involve several cells, sincewe found
correlations to both neutrophils, eosinophils and T-lym-
phocytes. Both the eosinophil and the neutrophil can
release large amounts of toxic oxygenradicals and a vari-ety of granule proteins with cytotoxic and potent enzy-
matic properties such as ECP, MBP, neutrophil elastase,
myeloperoxidase (MPO), lactoferrin and lipocalins,
which could take part in this damage. The correlations
toT-lymphocytes could indicate that these cells too play
a role in the direct damage of the epithelial cells. Amore
likely explanation for these relationships, however, is the
fact that activated lymphocytes may be involved in the
attraction and activation of eosinophils and neutrophils
in pSS.Other possible mechanisms behind the epithelial
damage observed in pSS include the dryness of the mu-
cousmembrane, which couldmake the epitheliummore
vulnerable to damage.The shedding of ciliated epithelial
cells frombasalcellsmaybecausedby thereleaseofTNFa
by macrophages or lymphocytes, the release of pro-
teases and other enzymes (22, 23) by several cell types,
or alternatively by submucosal oedema.
Thickened layers of laminin and tenascin are other
hallmarks of atopic asthma. The layers of laminin and
tenascin in pSSwere clearly thicker than in healthy sub-
jects, but less so than in atopic asthma (6). As noted
above our previous results on atopic asthma suggested
a role ofmast cells in the process (6). It is therefore intri-
guing to ¢nd a similar relationship in pSS, since thismight
suggest a causal relationship. It is well known that mast
cells bind to extracellular structures such as laminin (24)
and the activities of mast cells have been implicated in
the development of ¢brotic disorders (25).
A drawback with our study was that we have not
matched the patient group and control group for age
and sex.Thepatientgroupwas on average 20 years older
than the control group and we can therefore not totally
exclude that some of the di¡erences reported here may
be related to the age di¡erence.We are not aware if the
e¡ect of ageing on airway in£ammation has been studied
in detail. Inprevious investigationswehave, however, not
found any signi¢cant correlations between age and indir-
ect measures of airway in£ammation such as exhaled
NO or serum levels of eosinophil cationic protein in
healthy subjects (10, 26).
In conclusion, we found that the cellular pattern in the
bronchial mucosa of patients with pSS displayed large
numbers of neutrophils, mast cells and T-lymphocytes.
These changes in in£ammatory cell numbers seemed to
relate to the observed increased epithelial damage and
structural changes of the subepithelium. The structural
¢ndings, but not the pattern of in£ammatory cells, are
shared with atopic asthma and may relate to the
increased bronchial hyper-responsiveness seen in both
diseases.
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